-transparent.png){kind=logo}
Forty-four patients suffering from acute and chronic schizophrenic psychoses were used to obtain, by using Lorr's scale (IMPS) and taking the changes in disease state observed within three months as a base, suggestions or pointers as to the proper treatment of disease with fluphenazine (lyorodin) which is a neuroleptically highly potent phenothiazine derivative. Megalomania, grandiose delusions apathetic and depressive syndromes showed marked tendencies toward major improvement. An "antiautistic" effect was observed in chronic patients. The effective dose was between 6 and 12 mg a day. The drug was well tolerated. In the majority of cases it was also necessary for antiparkinsonian drugs to be administered to patients. After twelve months of treatment, slight to major improvements or even freedom from symptoms could be observed in 28 cases (or 64%).
H D Schulz, and
H H Kluge, and
W Korda, and
B Kube
April 1979,
Fortschritte der Medizin,
H D Schulz, and
H H Kluge, and
W Korda, and
B Kube
November 1981,
Nederlands tijdschrift voor geneeskunde,
H D Schulz, and
H H Kluge, and
W Korda, and
B Kube
October 1992,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
H D Schulz, and
H H Kluge, and
W Korda, and
B Kube
January 1982,
Biological psychiatry,
H D Schulz, and
H H Kluge, and
W Korda, and
B Kube
March 1963,
Wiener klinische Wochenschrift,
H D Schulz, and
H H Kluge, and
W Korda, and
B Kube
July 1998,
Pharmacopsychiatry,
H D Schulz, and
H H Kluge, and
W Korda, and
B Kube
January 1972,
Die Medizinische Welt,
H D Schulz, and
H H Kluge, and
W Korda, and
B Kube
July 1994,
Der Nervenarzt,
H D Schulz, and
H H Kluge, and
W Korda, and
B Kube
January 1986,
Monographien aus dem Gesamtgebiete der Psychiatrie,
H D Schulz, and
H H Kluge, and
W Korda, and
B Kube
February 1959,
Ceskoslovenska psychiatrie,
